comparemela.com
Home
Live Updates
Sensorion Reports 2023 First Half Results : comparemela.com
Sensorion Reports 2023 First Half Results
MONTPELLIER, France--(BUSINESS WIRE)--Sep 20, 2023--
Related Keywords
United Kingdom
,
Australia
,
United States
,
France
,
French
,
Australian
,
Nawal Ouzren
,
Institut Pasteur
,
Pierre Louis Germain
,
Eu Community Register
,
Health Products Safety
,
Regulatory Agency
,
Company Natural History Study
,
European Medicines Agency
,
Research Development
,
Drug Administration
,
French National Agency For Medicines
,
Research And Development Rd Expenses
,
Hereditary Monogenic Hearing
,
Good Manufacturing Practices
,
Clinical Trial Application
,
First Patient Inclusion
,
Orphan Drug Designation
,
Rare Pediatric Disease Designation
,
French National Agency
,
Medical Device Application
,
Natural History Study
,
Concept Phase
,
Cochlear Limited
,
Cisplatin Induced Ototoxicity
,
Sudden Sensorineural Hearing Loss
,
Pure Tone Audiometry
,
First Patient
,
Cash Equivalents
,
Half Year Financial Report
,
Drug Designations
,
Investor Relations
,
Louis Germain
,
Business Wire
,
Region
,
comparemela.com © 2020. All Rights Reserved.